On one hand, a line of research demonstrates a positive correlation, where studies using the ELISA method have found significantly higher visfatin levels in populations with clear metabolic dysfunction—such as patients with obesity and metabolic syndrome or in psoriasis patients who also present with metabolic syndrome—when compared to healthy controls [62,66,97]. The gene discussed is NAMPT; the disease is metabolic syndrome.